Study suggests liquid biopsy for colorectal cancer could guide therapy for tumours
A new study from Washington University School of Medicine in St. Louis demonstrates that a liquid biopsy examining blood or urine can help gauge the effectiveness of therapy for colorectal cancer that has just begun to spread beyond the original tumour.
Such a biopsy can detect lingering disease and could serve as a guide for deciding whether a patient should undergo further treatments due to some tumour cells evading an initial attempt to eradicate cancer.
The study appears online in the Journal of Clinical Oncology Precision Oncology, a journal of the American Society of Clinical Oncology.
While a few liquid biopsies have been approved by the Food and Drug Administration, mostly for lung, breast, ovarian, and prostate cancers, none has been approved for colorectal cancer.
Patie...